Alternative Data for TC BioPharm
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | N/A | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 5,396 | Sign up | Sign up | Sign up |
| X Followers | 897 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 22 | Sign up | Sign up | Sign up |
About TC BioPharm
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform.
| Price | $0.50 |
| Target Price | Sign up |
| Volume | 1,955,586 |
| Market Cap | $260,000 |
| Year Range | $0.5 - $0.5 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 0 | 1.1M | -1.1M | -2M | -2M | -6.056 |
| Q1 '24 | 0 | 2.2M | -2.2M | -3.3M | -3.4M | -22.360 |
| Q4 '23 | 0 | 0 | 0 | 0 | 0 | |
| Q2 '23 | 0 | 1.5M | -1.5M | 1M | -3.6M | |
| Q1 '23 | 0 | 2.2M | -2.2M | -630,000 | -4.2M |
Insider Transactions View All
| Renaissance Capital Partners Ltd filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Kenneth Edward filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Mark Edward filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Kenneth Edward filed to buy 70,000 shares at $0. January 11 '23 |
| Randall Mark Edward filed to buy 70,000 shares at $0. January 11 '23 |
Similar companies
Read more about TC BioPharm (TCBP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews & linkedin employees.
FAQ - TC BioPharm
The Market Cap of TC BioPharm is $260,000.
Currently, the price of one share of TC BioPharm stock is $0.50.
The TCBP stock price chart above provides a comprehensive visual representation of TC BioPharm's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling TC BioPharm shares. Our platform offers an up-to-date TCBP stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, TC BioPharm (TCBP) does not offer dividends to its shareholders. Investors interested in TC BioPharm should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of TC BioPharm are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
